Press Releases Abbott Laboratories

Equities

ABT

US0028241000

Market Closed - Nyse Other stock markets 01:30:02 25/06/2024 am IST			5-day change	1st Jan Change
105.3 ^USD	-0.40%		+1.79%	-4.33%

20/06	Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	CI
14/06	Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Abbott Laboratories : 2023 GLOBAL SUSTAINABILITY REPORT	21/06	PU
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	20/06	PR
Abbott Declares 402nd Consecutive Quarterly Dividend	17/06	AQ
Abbott Declares 402nd Consecutive Quarterly Dividend	14/06	PR
Abbott Laboratories : 2023 DIVERSITY, EQUITY, AND INCLUSION REPORT	13/06	PU
Abbott Laboratories : 2023 DIVERSITY AND INCLUSION REPORT	13/06	PU
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems	11/06	AQ
Abbott Laboratories : Receives CE Mark for AVEIR™ DR, the World's First Dual Chamber Leadless Pacemaker System	06/06	PU
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients	03/06	PR
Understanding Product-By-Process Claims In Patent Law	14/05	AQ
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX	01/05	AQ
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee	29/04	PR
Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range	17/04	AQ
Abbott: Q1 Earnings Snapshot	17/04	AQ
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges	17/04	PR
Practical Lessons From NCS Multistage Inc v. Kobold Corporation	12/04	AQ
ABBOTT RECEIVES FDA APPROVAL FOR TRICLIP, FIRST-OF-ITS-KIND DEVICE TO REPAIR LEAKY TRICUSPID HEART VALVE	03/04	AQ
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve	02/04	PR
Abbott Hosts Conference Call for First-Quarter Earnings	28/03	PR
Abbott Laboratories : Receives CE Mark for its Groundbreaking Assert-IQ™ Insertable Cardiac Monitor, Expanding Availability of Long-Term Monitoring for Irregular Heart Rhythms	25/03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Abbott Laboratories

Equities

ABT

US0028241000

Press Releases

Filters